Work

The Role of Pyroptosis in Shaping Antitumor Immunity and Evaluation of Pyroptosis-activating Immunotherapies for Solid Tumors

Year: 2020
Type: dissertation
Abstract: Many cytotoxic anticancer treatments activate cancer cell death, in turn triggering the anticancer immune response; however, the individual contribution of each type of cell death is largely unknown. Pyroptosis is an immunostimulatory cell death pathway that allows the release of pro-inflammatory biomolecules that stimulate anticancer immunity. In immunotherapy-responsive colorectal tumors, the induction of pyroptosis by expression of N-terminal Gasdermin E stimulates type I conventional dendritic cells (cDC1s) to drive anticancer CD8+ T cell responses. However, many immunosuppressive tumors exert mechanisms to resist therapy-induced immunogenicity. In particular, brain tumors, such as glioblastoma multiforme (GBM), present anatomical and tumor-intrinsic resistance mechanisms due to altered lymphatic drainage and vasculature as well as immunosuppressive tumor microenvironments. The goal of this thesis was to investigate the mechanisms and ability of pyroptosis to treat non-T cell-inflamed tumors. In distinct tumor types, growing in different anatomical locations, N-terminal Gasdermin E-induced pyroptosis activated pro-inflammatory cell death characterized by the release of pro-inflammatory damage-associated molecular patterns and cytokines, and increased recruitment of cDC1s exhibiting elevated co-stimulatory and migratory marker expression. Additionally, pyroptosis increased tumor antigen uptake and presentation in the context of MHC-I, leading to priming of functional tumor-specific CD8+ T cell responses, extending the survival of intracranial GBM tumor-bearing mice, dependent on both cDC1s and CD8+ T cells. Furthermore, the combination of pyroptosis and anti-PD-1 immune checkpoint inhibition remarkably prolonged the survival of intracranial GBM tumor-bearing mice. Finally, the development and application of pyroptosis-activating self-amplifying RNA replicons resulted in the prolonged survival of intracranial GBM tumor-bearing mice. Taken together, these findings suggest that intratumoral activation of pyroptosis in brain tumors stimulates the cDC1-CD8+ T cell axis, leading to improved antitumor immunity and prolonged survival of tumor-bearing mice. Hence, the activation of pyroptosis in combination with anti-PD-1 therapy may provide promising alternatives for the treatment of immunosuppressive GBM tumors.
Language: English
Open Access status: green
OpenAlex ID: W7213573288
Cites: 109
Cited by:
Related to: 10